Modulation of cardiac contractility in patients with chronic heart failure and atrial fibrillation
- 作者: Uskach T.1,2, Safiullina A.1, Sapel’nikov O.1, Amanatova V.1, Nikolaeva O.3, Grishin I.1, Nazarov B.4, Tereshchenko S.1,2
-
隶属关系:
- National Medical Research Center for Cardiology
- Russian Medical Academy of Continuous Professional Education
- Davydovsky Сity Clinical Hospital
- City Polyclinic №191
- 期: 卷 92, 编号 9 (2020)
- 页面: 8-14
- 栏目: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/46845
- DOI: https://doi.org/10.26442/00403660.2020.09.000598
- ID: 46845
如何引用文章
全文:
详细
Aim. to evaluate the effectiveness of cardiac contractility modulation (MSS) in patients with chronic heart failure (CHF) and atrial fibrillation (AF).
Materials and methods. The following studies were performed in 40 patients with CHF and AF before implantation of the MSS device and after 2 and 6 months of follow-up: 12-channel ECG, transthoracic EchoCG, 6-minute walk test, determination of the level of Pro-natriuretic N-terminal peptide (NT-proBNP), daily ECG monitoring, and a questionnaire based on the Minnesota quality of life questionnaire for patients with CHF (MHFLQ). All patients received long-term optimal drug therapy for CHF before surgery.
Results. The results obtained indicate a statistically significant positive effect of the use of MSS in patients with CHF and AF on LV FV, the functional class of CHF, and levels of NT-proBNP regardless of the etiology of CHF.
Conclusion. The use of MSS may be promising for the treatment of heart failure in patients with CHF and AF.
作者简介
T. Uskach
National Medical Research Center for Cardiology; Russian Medical Academy of Continuous Professional Education
Email: a_safiulina@mail.ru
ORCID iD: 0000-0003-4318-0315
д.м.н., в.н.с. отд. заболеваний миокарда и сердечной недостаточности ФГБУ «НМИЦ кардиологии», проф. каф. кардиологии ФГБУ ДПО РМАНПО
俄罗斯联邦, MoscowA. Safiullina
National Medical Research Center for Cardiology
编辑信件的主要联系方式.
Email: a_safiulina@mail.ru
ORCID iD: 0000-0003-3483-4698
к.м.н., н.с. отд. заболеваний миокарда и сердечной недостаточности ФГБУ «НМИЦ кардиологии»
俄罗斯联邦, MoscowO. Sapel’nikov
National Medical Research Center for Cardiology
Email: a_safiulina@mail.ru
ORCID iD: 0000-0002-5186-2474
д.м.н., рук. лаб. хирургических и рентгенхирургических методов лечения нарушений ритма сердца отд. сердечно-сосудистой хирургии ФГБУ «НМИЦ кардиологии»
俄罗斯联邦, MoscowV. Amanatova
National Medical Research Center for Cardiology
Email: a_safiulina@mail.ru
ORCID iD: 0000-0002-0678-9538
ординатор отд. заболеваний миокарда и сердечной недостаточности ФГБУ «НМИЦ кардиологии»
俄罗斯联邦, MoscowO. Nikolaeva
Davydovsky Сity Clinical Hospital
Email: a_safiulina@mail.ru
ORCID iD: 0000-0001-6833-8938
к.м.н, врач терапевт/кардиолог, ГБУЗ «ГКБ №23 им. И.В. Давыдовского», центр персонализированной медицины
俄罗斯联邦, MoscowI. Grishin
National Medical Research Center for Cardiology
Email: a_safiulina@mail.ru
ORCID iD: 0000-0002-2689-2751
к.м.н., сердечно-сосудистый хирург отд. сердечно-сосудистой хирургии ФГБУ «НМИЦ кардиологии»
俄罗斯联邦, MoscowB. Nazarov
City Polyclinic №191
Email: a_safiulina@mail.ru
ORCID iD: 0000-0003-2145-1284
к.м.н., врач-кардиолог, зав. филиалом №3 ГБУЗ ГП №191
俄罗斯联邦, MoscowS. Tereshchenko
National Medical Research Center for Cardiology; Russian Medical Academy of Continuous Professional Education
Email: a_safiulina@mail.ru
ORCID iD: 0000-0001-9234-6129
д.м.н., проф., рук. отд. заболеваний миокарда и сердечной недостаточности ФГБУ «НМИЦ кардиологии», зав. каф. кардиологии ФГБУ ДПО РМАНПО
俄罗斯联邦, Moscow参考
- Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93(9):1137-46. doi: 10.1136/hrt. 2003.025270
- Фомин И.В., Беленков Ю.Н., Мареев В.Ю. и др. Распространенность хронической сердечной недостаточности в Европейской части Российской Федерации – данные ЭПОХА-ХСН (Часть II). Сердечная Недостаточность. 2006;7(3):112-5 [Fomin IV, Belenkov YuN, Mareev VYu, et al. Prevalence of chronicheart failure in European part of Russian Federation – Data of AGECHF (Part II). Russian Heart Failure Journal. 2006;7(1):112-5 (In Russ.)].
- Жиров И.В., Романова Н.В., Терещенко С.Н., Осмоловская Ю.Ф. Эпидемиология и особенности терапии хронической сердечной недостаточности в сочетании с фибрилляцией предсердий. Кардиология. 2015;55(3):91-6 [Zhirov IV, Romanova NV, Tereshchenko SN, Osmolovskaya YuF. Epidemiology and management of heart failure patients with atrial fibrillation. Kardiologiia. 2015;55(3):91-6 (In Russ.)]. doi: 10.18565/cardio.2015.3.91–96
- Rasoul D, Ziaei F, Shan S, et al. 11 The Decennial Relationship between Heart Failure and Atrial Fibrillation – A Large Population Study. Heart. 2016;102(Suppl. 6):A7.2-A8. doi: 10.1136/heartjnl-2016-309890.11
- Zafrir B, Lund LH, Laroche C, et al; Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry. Eur Heart J. 2018;39(48):4277-84. doi: 10.1093/eurheartj/ehy626
- Pocock SJ, Ariti CA, McMurray JJV, et al; Meta-Analysis Global Group in Chronic Heart Failure. Predicting survival in heart failure: A risk score based on 39,372 patients from 30 studies. Eur Heart J. 2013;34(19):1404-13. doi: 10.1093/eurheartj/ehs337
- Swedberg K, Olsson LG, Charlesworth A, et al. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. Eur Heart J. 2005;26(13):1303-8. doi: 10.1093/eurheartj/ehi166
- Терещенко С.Н., Жиров И.В., Романова Н.В. и др. Первый Российский регистр больных хронической сердечной недостаточностью и фибрилляцией предсердий (РИФ-ХСН): дизайн исследования. Рациональная фармакотерапия в кардиологии. 2015;11(6):577-81 [Tereshchenko SN, Zhirov IV, Romanova NV, et al. The first Russian registry of patients with chronic heart failure and atrial fibrillation (RIF-CHF): research design. Rational Pharmacotherapy in Cardiology. 2015;11(6):577-81 (In Russ.)]. doi: 10.20996/1819-6446-2015-11-6-577-581
- Brignole M, Auricchio A, Baron-Esquivias G, et al. ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34:2281-329. doi: 10.15829/1560-4071-2014-4-5-63
- Lund LH, Jurga J, Edner M, et al. Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction. Eur Heart J. 2013;34(7):529-39. doi: 10.1093/eurheartj/ehs305
- Ponikowski P, Voors AA, Anker SD, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-200. doi: 10.1093/eurheartj/ehw128
- Cheng A, Landman SR, Stadler RW. Reasons for loss of cardiac resynchronization therapy pacing: insights from 32 844 patients. Circulation: Arrhythmia Electrophysiol. 2012; 5(5):884-8. doi: 10.1161/CIRCEP.112.973776
- Kosztin A, Boros AM, Geller L, Merkely B. Cardiac resynchronisation therapy: current benefits and pitfalls. Kardiologia Polska. 2018;76(10):1420-5. doi: 10.5603/KP.a2018.0160
- Ruschitzka F, Abraham WT, Singh JP, et al. EchoCRT Study Group. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med. 2013;369(15):1395-405. doi: 10.1056/NEJMoa1306687
- Kuck KH, Bordachar P, Borggrefe M, et al. New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association. Europace. 2014;16:109-28. doi: 10.1093/europace/eut311
- Abi-Samra F, Gutterman D. Cardiac contractility modulation: a novel approach for the treatment of heart failure. Heart Fail Rev. 2016;21(6):645-60. doi: 10.1007/s10741-016-9571-6
- Borggrefe MM, Lawo T, Butter C, et al. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J. 2008;29(8):1019-28. doi: 10.1093/eurheartj/ehn020
- Kadish A, Nademanee K, Volosin K, et al. A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart J. 2011;161(2):329-37.e2. doi: 10.1016/j.ahj.2010.10.025
- Abraham WT, Nademanee K, Volosin K, et al. Subgroup Analysis of a Randomized Controlled Trial Evaluating the Safety and Efficacy of Cardiac Contractility Modulation in Advanced Heart Failure. J Cardiac Fail. 2011;17(9):710-7. doi: 0.1016/j.cardfail.2011.05.006
- Schau T, Seifert M, Meyhofer J, et al. Long-term outcome of cardiac contractility modulation in patients with severe congestive heart failure. Europace. 2011;13(10):1436-44. doi: 10.1093/ europace/eur153
- Kuschyk J, Roeger S, Schneider R, et al. Efficacy and survival in patients with cardiac contractility modulation: Long-term single center experience in 81 patients. Int J Cardiol. 2015;183:76-81. doi: 10.1016/ j.ijcard.2014.12.178
- Kloppe A, Lawo T, Mijic D, et al. Longterm survival with Cardiac Contractility Modulation in patients with NYHA II or III symptoms and normal QRS duration. Int J Cardiol. 2016;209:291-5. doi: 10.1016/j.ijcard. 2016.02.001
- Liu M, Fang F, Luo XX, et al. Improvement of long-term survival by cardiac contractility modulation in heart failure patients: A case-control study. Int J Cardiol. 2016;206:122-6. doi: 10.1016/j.ijcard.2016.01.071
- Grigioni F, Carinci V, Boriani G, et al. Accelerated QRS widening as an independent predictor of cardiac death or of the need for heart transplantation in patients with congestive heart failure. J Heart Lung Transplant. 2002;21(8):899-902. PMID: 12163090.
- Röger S, Michels J, Heggemann F, et al. Long term impact of cardiac contractility modulation on QRS duration. J Electrocardiol. 2014;47(6):936-40. doi: 10.1016/j.jelectrocard.2014.08.011
- Nagele H, Behrens S, Eisermann C. Cardiac contractility modulation in non-responders to cardiac resynchronization therapy. Europace. 2008;10(12):1375-80. doi: 10.1093/europace/eun257
- Kloppe A, Boesche L, Aweimer A, et al. Acute and short term safety and feasibility of the new OPTIMIZER SMART-system: Is it reasonable to avoid an atrial lead? EP Europace. 2018;20(Suppl. 1):i48. doi: 10.1093/europace/euy015.128
- Ревишвили А.Ш., Артюхина Е.А, Амирасланов А.Ю. и др. Первый опыт лечения пациентов с хронической сердечной недостаточностью методом имплантации устройств, модулирующих сокращения сердца. Вестн. аритмологии. 2017;90:12-8 [Revishvili ASh, Artyukhina EA, Amiraslanov AYu, et al. The first experience of treatment of patients with chronic heart failure using cardiac contractility modulation device. Journal of Arrhythmology. 2017;90:12-8 (In Russ.)].
- Seferovic PM, Ponikowski P, Anker SD, et al. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21(10):1169-86. doi: 10.1002/ejhf.1531
- Stix G, Borggrefe M, Wolpert C, et al. Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure. Eur Heart J. 2004;25(8):650-5. doi: 10.1016/j.ehj.2004.02.027
- Abraham WT, Kuck KH, Goldsmith RL, et al. Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation. JACC Heart Fail. 2018;6(10):874-83. doi: 10.1016/j.jchf.2018.04.010